4//SEC Filing
Paramore Miriam J 4
Accession 0001213900-21-056471
CIK 0001448431other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 4:45 PM ET
Size
8.3 KB
Accession
0001213900-21-056471
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Paramore Miriam J
PRESIDENT
Transactions
- Sale
Common Stock Pursuant to 10B5-1 Plan
2021-11-02$95.45/sh−15,000$1,431,750→ 74,607 total - Exercise/Conversion
Stock Option
2021-11-02−15,000→ 94,318 totalExercise: $7.51From: 2020-12-31Exp: 2025-03-11→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2021-11-02$7.51/sh+15,000$112,650→ 89,607 total
Footnotes (1)
- [F1]These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001713156
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 4:45 PM ET
- Size
- 8.3 KB